Lidak Pharmaceuticals has licensed Lidakol to CTS ChemicalIndustries Ltd. in Kiryat Malachi, Israel, for regulatoryapproval, manufacture, promotion and distribution in Israel.Lidak (NASDAQ:LDAKA) of La Jolla, Calif., has started its thirdPhase II trial of Lidakol in herpes infections.

(c) 1997 American Health Consultants. All rights reserved.